verapamil has been researched along with Urinary Bladder, Neurogenic in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Urinary Bladder, Neurogenic: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekström, B | 2 |
Hassouna, M | 1 |
Nishizawa, O | 1 |
Miyagawa, I | 1 |
Toguri, A | 1 |
Gotoh, M | 1 |
Elhilali, M | 1 |
Mattiasson, A | 1 |
Andersson, KE | 1 |
3 other studies available for verapamil and Urinary Bladder, Neurogenic
Article | Year |
---|---|
Intravesical instillation of drugs in patients with detrusor hyperactivity.
Topics: Administration, Intravesical; Animals; Atropine; Butylamines; Female; Humans; Parasympatholytics; Ph | 1992 |
Role of calcium ion antagonists of the bladder detrusor muscle: in vitro and in vivo study.
Topics: Animals; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Ion Channels; Male; Mu | 1986 |
Effects of intravesical instillation of verapamil in patients with detrusor hyperactivity.
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Uri | 1989 |